Segment Information - Summary of Summarized Financial Information for the Company's Segments (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information
Consolidated revenue	$ 82,035,000		$ 64,977,000	$ 238,451,000	$ 181,059,000
Total segment depreciation expense	914,000		393,000	2,056,000	1,066,000
Total segment amortization	784,000		741,000	2,240,000	2,153,000
Goodwill impairment charges	0	$ 16,867,000	0	16,867,000	0
Selling, general and administrative expense	28,205,000		31,963,000	85,761,000	90,117,000
Non-segment depreciation and amortization	1,698,000		1,134,000	4,296,000	3,219,000
Loss from operations	(13,925,000)		(20,097,000)	(61,730,000)	(56,872,000)
Operating segments
Segment Reporting Information
Consolidated revenue	82,035,000		64,977,000	238,451,000	181,059,000
Total segment direct costs	66,057,000		51,977,000	193,257,000	144,595,000
Total segment depreciation expense	780,000		317,000	1,677,000	852,000
Total segment amortization	784,000		741,000	2,240,000	2,153,000
Total segment operating income	14,414,000		11,942,000	41,277,000	33,459,000
Goodwill impairment charges	0		0	16,867,000	0
Selling, general and administrative expense	28,205,000		31,963,000	85,761,000	90,117,000
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	134,000		76,000	379,000	214,000
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	53,634,000		44,627,000	157,333,000	118,793,000
Total segment direct costs	44,961,000		36,126,000	132,653,000	96,379,000
Total segment depreciation expense	749,000		316,000	1,601,000	848,000
Total segment amortization	731,000		688,000	2,082,000	1,995,000
Total segment operating income	7,193,000		7,497,000	20,997,000	19,571,000
Goodwill impairment charges	0		0	16,235,000	0
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	26,792,000		18,839,000	76,228,000	57,736,000
Total segment direct costs	21,072,000		15,738,000	60,328,000	47,816,000
Total segment depreciation expense	30,000		0	75,000	0
Total segment amortization	0		0	0	0
Total segment operating income	5,690,000		3,101,000	15,825,000	9,920,000
Goodwill impairment charges	0		0	0	0
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	1,609,000		1,511,000	4,890,000	4,530,000
Total segment direct costs	24,000		113,000	276,000	400,000
Total segment depreciation expense	1,000		1,000	1,000	4,000
Total segment amortization	53,000		53,000	158,000	158,000
Total segment operating income	1,531,000		1,344,000	4,455,000	3,968,000
Goodwill impairment charges	$ 0		$ 0	$ 632,000	$ 0